Therefore, the targets of the PI3K/Akt pathway are critical because treatments of T2DM function involve the impairment of this signaling pathway in muscles, all of which causes hyperglycemia and insulin resistance (10, 15). Here, AKT1 is linked to type 2 diabetes mellitus.